跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
HSA
/
CO-ERBETAN FILM-COATED TABLET 300MG/12.5MG
Approved
THERAPEUTIC
CO-ERBETAN FILM-COATED TABLET 300MG/12.5MG
Macleods Pharmaceuticals Limited
🇸🇬 Health Sciences Authority
Approval Date
Feb 20, 2017
Approval ID
42f66a66f6ab791e
Company
Macleods Pharmaceuticals Limited
Type
Therapeutic
Approval Details
Approval Id
42f66a66f6ab791e
Drug Name
CO-ERBETAN FILM-COATED TABLET 300MG/12.5MG
Product Name
CO-ERBETAN FILM-COATED TABLET 300MG/12.5MG
Approval Number
SIN15178P
Approval Date
2017-02-20
Registrant
GOLDPLUS UNIVERSAL PTE LTD
Licence Holder
GOLDPLUS UNIVERSAL PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET, FILM COATED
Route Of Administration
ORAL
Atc Code
C09DA04
Atc Item Name
irbesartan and diuretics
Pharma Manufacturer Name
GOLDPLUS UNIVERSAL PTE LTD
Company Detail Path
/organization/goldplus-universal-pte-ltd
Active Ingredients
Hydrochlorothiazide
12.50mg
Irbesartan
300.00mg
Hydrochlorothiazide
12.50mg
Irbesartan
300.00mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Feb 20, 2017
Approval ID
42f66a66f6ab791e
Type
Therapeutic
Back to HSA Approvals
